Latest News

Wednesday, January 16, 2019

#RealDealAesthetics Takes on Minimally Invasive Body Contouring

Save the date:  Practical Dermatology®'s sister publication Modern Aesthetics’ newest Tweet chat series -- #RealDealAesthetics  -- featuring New York City dermatologist Ga…

Read the full story

Wednesday, January 16, 2019

Dermatologists Prescribe the Most Antibiotics, but Usage is Changing

The use of antibiotics to treat inflammatory skin conditions like acne and rosacea is decreasing over time, but there has been an increase in prescriptions associated with dermatologic surgical proced…

Read the full story

Tuesday, January 15, 2019

New Review Highlights Comprehensive Treatment Guidelines for Severe AD

A team of investigators from the University of Colorado College of Nursing at CU Anschutz Medical Campus and National Jewish Health has identified comprehensive guidelines for managing severe atopic d…

Read the full story

Tuesday, January 15, 2019

Study: States with Fewer Melanoma Diagnoses Have Higher Death Rates

States with fewer melanoma diagnoses actually have higher death rates, report researchers at University of Utah Health. The researchers conducted a state-by-state analysis to understand the geograp…

Read the full story

Tuesday, January 15, 2019

Real Housewife Gets Real About Self-Care, Coolsculpting

Bravo's "The Real Housewives of New York City” Sonja Morgan is the face of Coolscuplting’s new "Let's Get Real About Self-Care" campaign. Morgan joins CoolSculpti…

Read the full story

Monday, January 14, 2019

L’Occitane to Buy ELEMIS for $900 Million

L’Occitane International S.A. has entered into a definitive agreement to acquire ELEMIS, the number one luxury British skincare brand, for $900 million in cash. ELEMIS is being sold by Steiner L…

Read the full story

Monday, January 14, 2019

Peak Health Launches Plant-Based Regenerative Skincare Line

Peak Health, launched Curere, a patented, regenerative skin care line created to treat a range of skin conditions, including acne, third-degree burns and necrosis. The line is made from all-natural…

Read the full story

Wednesday, January 09, 2019

Dermatology Hall of Fame to Recognize Industry Pioneers

The Dermatology Hall of Fame will honor its first inductees February 28, 2019, in Washington, DC. The organization, founded in 2018, was established to recognize and honor past and present luminaries …

Read the full story

Wednesday, January 09, 2019

LEO Pharma Focuses on Translational Medicine, Appoints Dr. Adam B. Raff as Director & Medical Advisor

LEO Pharma has appointed Adam B. Raff, MD, PhD as Director and Medical Advisor in Translational Medicine, effective January 28. Dr. Raff’s primary objective will be to support LEO Pharma’s…

Read the full story

Monday, January 07, 2019

“Outstanding Clearance Rates” for Sebaceous Hyperplasia Facial Lesions Seen with NPS

Pulse Biosciences' Nano-Pulse Stimulation (NPS) technology achieved “outstanding clearance rates” on sebaceous hyperplasia lesions on the face, the company reports. I…

Read the full story

Monday, January 07, 2019

Leadership Changes Announced for Cutera

Cutera, Inc.'s James Reinstein resigned as President, Chief Executive Officer, and member of its Board of Directors, effective immediately. The Board has appointed Cutera’s Chief Operating O…

Read the full story

Friday, January 04, 2019

“Christmas Berry” Plant Compound Could Fight Uveal Melanoma

A compound extracted from the Christmas berry primrose plant may stops the growth of uveal melanoma, according to  preliminary tests. With further testing, the discovery could lead to new ther…

Read the full story

Thursday, January 03, 2019

Suneva Grows Their Aesthetics Portfolio with New Deals

  Suneva® Medical, Inc., is partnering with Healeon Medical, Inc and Puregraft, LLC to add two new products to their aesthetics portfolio.  Healeon Medical…

Read the full story

Thursday, January 03, 2019

JAK Kinase Inhibitors Show Promise in Treating Alopecia

UPDATED -- New research suggests selective oral JAK kinase inhibitors may play a role in treating moderate-to-severe alopecia areata (AA).  The findings were presented at the Inflammatory Skin Di…

Read the full story

Thursday, January 03, 2019

Bristol-Myers Squibb to Acquire Celgene

Bristol-Myers Squibb Company will acquire Celgene Corp. in a cash and stock transaction with an equity value of approximately $74 billion. The combined company with complementary areas of focus, will …

Read the full story
Load More
 Stock Price  Change 
 AbbVie $85.55  0.06% 
 Allergan $152.89  0.13% 
 Amgen $198.89  -0.25% 
 Bayer AG $18.53  -0.54% 
 Celgene $87.30  -1.05% 
 Cutera $14.11  -0.77% 
 GlaxoSmithKline $38.41  -1.64% 
 Johnson and Johnson $128.04  -1.02% 
 Lily $116.80  -0.25% 
 Nestle $84.01  -0.80% 
 Novartis $87.95  0.09% 
 Pfizer $42.11  -1.45% 
 Proctor and Gamble $91.37  -0.70% 
 Taro $91.60  0.36% 
 Unilever $52.62  -1.29%